L
Lyell Immunopharma (LYEL)
$000.00 0.00% ($0.00)
- Today
- Week
- Month
- Year
- 5 Year
- YTD
getbaraka.com
About Lyell Immunopharma (LYEL)
Lyell Immunopharma, Inc is a T cell reprogramming company. The Company offers T cells to cure patients with solid tumors. Its technologies are designed to be applied in a target and agnostic manner to chimeric antigen receptor (CAR), tumor-infiltrati... Read more
- USD11.42
- USD12.05
- USD10.87
- USD53.50
- 31.90%
- 75.91k
- 189.41k
- 129M
- 7.65
- -78.60%
Stock News
2 hours ago
May jobs report shows soft 139,000 increase in new workers. Trade wars sap hiring.
MarketWatch
3 hours ago
Yes, Top Funds Love Meta, Nvidia And Palantir. But They Go Absolutely Nuts For This AI Stock.
Yahoo
6 hours ago
Nvidia's Explosive Growth Potential Could Exceed Market's Expectations
SeekingAlpha
6 hours ago
Nintendo: Switch 2 Is Out, But Maybe Pause Before You Press Buy
SeekingAlpha
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
